Endologix Inc. To Participate In Two Investor Conferences In May

Published: May 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif., May 2, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and Chief Executive Officer, and Shelley Thunen, Chief Financial Officer, are scheduled to participate at two investor conferences in May. The first conference is the Deutsche Bank 39th Annual Health Care Conference in Boston, MA.

Help employers find you! Check out all the jobs and post your resume.

Back to news